Long‐term changes in liver elasticity in hepatitis C virus‐infected patients with sustained virologic response after treatment with direct‐acting antivirals

V. Pietsch, Katja Deterding, Dina Attia, Kristina I. Ringe, Benjamin Heidrich, Markus Cornberg, M Gebel, Michael P. Manns, Heiner Wedemeyer, Andrej Potthoff

United European Gastroenterology Journal · 2018 · 37 citations · 30 references

DOIFull text

Open access

Concepts

Abstract

BACKGROUND: The use of interferon-free direct-acting antiviral agents (DAAs) is associated with a rapid short-term decrease in liver stiffness in chronic hepatitis C-infected patients with sustained virologic response (SVR). OBJECTIVE: The objective of this article is to evaluate long-term changes in liver elasticity in hepatitis C patients with SVR using transient elastography (TE), FIB-4 and APRI. METHODS: A total of 143 patients were treated with DAAs and reached SVR. Patients received TE measurement (median (range)) at treatment start (baseline), follow-up week 24 (FU24) and follow-up week 96 (FU96). Laboratory data were examined at each date and FIB-4 and APRI were calculated. RESULTS: < 0.0001). Liver inflammation and liver function parameters normalised during long-term follow-up. Progression of liver stiffness between FU24 to FU96 despite viral clearance was observed in 24 patients (17%). Long-term liver stiffness progression was associated with aspartate aminotransferase levels and TE change from baseline to FU24. CONCLUSION: During long-term follow-up, the majority of patients with SVR had further improved liver stiffness values. Still, a significant proportion of patients may show long-term liver stiffness progression and thus continued TE follow-up is recommended.

References

30